FDA Import Refusal 1FX-7668302-8/10002/7 — CIPLA HEALTHCARE
The FDA refused shipment 1FX-7668302-8/10002/7 from CIPLA HEALTHCARE (India) on Aug 13, 2026. The refused product falls under Drugs and Biologics — ACETAMINOPHEN (ANALGESIC). Cited charges: 118,75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Aug 13, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60LDY01 ACETAMINOPHEN (ANALGESIC)
- Charges
- 118,75